FDA
-
-
-
-
-
-
-
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
-
-
-
-
-
-
-
Anteris receives European clearance for heart valve trial
-
-
-
-
-
-
-
Anteris Announces Results for the First Quarter of 2025
-
-
-
-
-
-
-
Anteris Announces Completion of A$35 Million Capital Raise and Provides 2023 Goalposts
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

